These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 19126053
21. Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphoma. Shapiro M, Rook AH, Lehrer MS, Junkins-Hopkins JM, French LE, Vittorio CC. J Am Acad Dermatol; 2002 Dec; 47(6):956-61. PubMed ID: 12451388 [No Abstract] [Full Text] [Related]
30. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin. Martín JM, Nicolau MJ, Galán A, Ferrández-Izquierdo A, Ferrer AM, Jordá E. J Eur Acad Dermatol Venereol; 2006 Oct 01; 20(9):1129-32. PubMed ID: 16987271 [Abstract] [Full Text] [Related]
33. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas. Chuang SS, Chang ST, Chuang WY, Huang WT, Hsieh PP, Tsou MH, Liao YL, Lin SH, Hsieh YC, Lu CL, Sheu MJ, Liu H. Am J Surg Pathol; 2009 Aug 01; 33(8):1230-40. PubMed ID: 19561449 [Abstract] [Full Text] [Related]
34. Primary cutaneous blastic natural killer-cell lymphoma. Conde-Taboada A, De La Torre C, Alcázar JJ, Dios A, Flórez A, Rosón E, Cruces M. Acta Derm Venereol; 2006 Aug 01; 86(3):269-70. PubMed ID: 16710598 [No Abstract] [Full Text] [Related]
36. Pathogenesis and therapy of cutaneous lymphomas--progress or impasse? Dummer R, Cozzio A, Urosevic M. Exp Dermatol; 2006 May 01; 15(5):392-400. PubMed ID: 16630081 [Abstract] [Full Text] [Related]
39. [Blastic natural killer cell leukemia--one case report and review of literature]. Guo XN, Wang CY, Wang Y, Xu SR, Ren JH, Lin FR, Yao EG. Zhonghua Xue Ye Xue Za Zhi; 2003 Jul 01; 24(7):362-4. PubMed ID: 12941191 [Abstract] [Full Text] [Related]